
MGTA
Healthcare · Biotechnology · $45.1M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2023
EPS trend, 90 days to now · -100.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 3, 2023 | Before the open | -0.19 | -0.05 | +73.7% |
| May 15, 2023 | After the close | -0.41 | -0.48 | -17.3% |
| Mar 23, 2023 | Before the open | -0.27 | -0.34 | -25.9% |
| Nov 3, 2022 | Before the open | -0.30 | -0.27 | +10.0% |
| Aug 4, 2022 | Before the open | -0.33 | -0.29 | +12.1% |
| May 16, 2022 | Before the open | -0.31 | -0.39 | -25.8% |
| Mar 8, 2022 | Before the open | -0.32 | -0.33 | -3.1% |
| Nov 4, 2021 | Before the open | -0.33 | -0.30 | +9.1% |
| Aug 5, 2021 | Before the open | -0.38 | -0.32 | +15.8% |
| May 6, 2021 | Before the open | -0.40 | -0.36 | +10.0% |
| Mar 3, 2021 | Before the open | -0.42 | -0.38 | +9.5% |
| Nov 5, 2020 | Before the open | -0.45 | -0.37 | +17.8% |
| Aug 6, 2020 | Before the open | -0.54 | -0.48 |
Magenta Therapeutics, Inc., a biotechnology company focus on improving stem cell transplantation. Its product candidates are designed to bring the curative power of stem cell transplant to patients with blood cancers, genetic diseases, and autoimmune diseases. The company's product portfolio includes MGTA-117, an anti-CD117 antibody conjugated to an amanitin payload that targets hematopoietic stem cells (HSCs) and…
| +11.1% |
| May 7, 2020 | Before the open | -0.59 | -0.51 | +13.6% |
| Mar 3, 2020 | Before the open | -0.59 | -0.59 | 0.0% |
| Nov 13, 2019 | Before the open | -0.54 | -0.54 | 0.0% |
| Aug 8, 2019 | Before the open | -0.53 | -0.48 | +9.4% |
| May 9, 2019 | Before the open | -0.57 | -0.44 | +22.8% |
| Mar 19, 2019 | Before the open | -0.56 | -0.50 | +10.7% |
| Nov 8, 2018 | Before the open | -0.67 | -0.49 | +26.9% |
| Aug 9, 2018 | After the close | -1.10 | -3.13 | -184.5% |
| May 24, 2018 | After the close | 0.00 | -4.45 | — |
| Feb 3, 2018 | Time not confirmed | — | -1.03 | — |